Hi all,
any thoughts on the outcome? Looks great so far
• Plasma concentrations of PBT434 in plasma strongly correlate with CSF levels in both humans and mouse
” PBT434 at 200 to 250 mg bid achieve CSF levels greater than in mice dosed at 30 mg/kg/day – a dose level associated with robust efficacy in an MSA mouse model”
Ann: Alterity presents initial Phase 1 clinical trial data at AAN, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $147.3M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 1914491 | 1.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.6¢ | 649000 | 3 |
View Market Depth
| Last trade - 09.47am 28/07/2025 (20 minute delay) ? |
| ATH (ASX) Chart |
Day chart unavailable